Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 31 of 618 for:    Hemorrhage AND postpartum

Study of Biological Determinants of Bleeding Postpartum (HPP-IPF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02884804
Recruitment Status : Completed
First Posted : August 31, 2016
Last Update Posted : August 31, 2016
Sponsor:
Information provided by (Responsible Party):
University Hospital, Brest

Brief Summary:

At the entry of the delivery room, a standard blood analysis will be performed (Blood count, PT, aPTT, Fibrinogen, and D-Dimer) for each women (if they are agree), according to the center's practices.

The percentage of the immature platelets is a an additional parameter on the hemogram.

The clinical assessments (recorded in medical records) and biological values will be used to determine if there is a correlation between these data and the occurrence of postpartum hemorrhage.


Condition or disease
Postpartum Hemorrhage

Layout table for study information
Study Type : Observational
Actual Enrollment : 3599 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Study of Biological Determinants of Bleeding Postpartum : Predictive Role in the Number of Immature Platelets
Study Start Date : November 2011
Actual Primary Completion Date : May 2015
Actual Study Completion Date : May 2015

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Postpartum Hemorrhage [ Time Frame: Volume of blood loss up to 24 hours after delivery and / or weight compresses collected at delivery, and / or diagnosis of the clinician ]
  2. Percentage of immature platelets [ Time Frame: Percentage of immature platelets just before the entry in the birth room ]

Biospecimen Retention:   Samples Without DNA
PLASMA


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Woman giving birth in a maternity of Finistère (France)
Criteria

Inclusion Criteria:

  • Woman giving birth in a maternity of Finistère

Exclusion Criteria:

  • Refuse to participate in the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02884804


Locations
Layout table for location information
France
CHRU de BREST
Brest, France
Sponsors and Collaborators
University Hospital, Brest
Investigators
Layout table for investigator information
Principal Investigator: PAN-PETESCH Brigitte, Dr. CHRU de BREST

Layout table for additonal information
Responsible Party: University Hospital, Brest
ClinicalTrials.gov Identifier: NCT02884804     History of Changes
Other Study ID Numbers: HPP-IPF (RB 11.080)
First Posted: August 31, 2016    Key Record Dates
Last Update Posted: August 31, 2016
Last Verified: August 2016

Keywords provided by University Hospital, Brest:
Postpartum Hemorrhage
Immature platelet

Additional relevant MeSH terms:
Layout table for MeSH terms
Postpartum Hemorrhage
Hemorrhage
Pathologic Processes
Obstetric Labor Complications
Pregnancy Complications
Puerperal Disorders
Uterine Hemorrhage